Showing 1 - 7 results of 7 for search 'Letizia Foroni', query time: 0.03s Refine Results
  1. 1
    Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation

    Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation by Dragana Milojkovic, Amr Ibrahim, Alistair Reid, Letizia Foroni, Jane Apperley, David Marin

    Published 2012-03-01
    Get full text
    Article
  2. 2
    E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy

    E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy by Simone Claudiani, Jane F. Apperley, Robert Peter Gale, Richard Clark, Richard Szydlo, Simona Deplano, Renuka Palanicawandar, Jamshid Khorashad, Letizia Foroni, Dragana Milojkovic

    Published 2017-08-01
    Get full text
    Article
  3. 3
    MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia

    MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia by Simone Claudiani, Aoife Gatenby, Richard Szydlo, George Nesr, Adi Shacham Abulafia, Renuka Palanicawandar, Georgios Nteliopoulos, Jamshid Khorashad, Letizia Foroni, Jane F. Apperley, Dragana Milojkovic

    Published 2019-11-01
    Get full text
    Article
  4. 4
    The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib

    The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib by Jamshid Sorouri Khorashad, Simon Wagner, Liat Greener, David Marin, Alistair Reid, Dragana Milojkovic, Hetal Patel, Shaun Willimott, Katy Rezvani, Gareth Gerrard, Sandra Loaiza, John Davis, John Goldman, Junia Melo, Jane Apperley, Letizia Foroni

    Published 2009-06-01
    Get full text
    Article
  5. 5
    Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors

    Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors by Georgios Nteliopoulos, Alexandra Bazeos, Simone Claudiani, Gareth Gerrard, Edward Curry, Richard Szydlo, Mary Alikian, Hui En Foong, Zacharoula Nikolakopoulou, Sandra Loaiza, Jamshid S. Khorashad, Dragana Milojkovic, Danilo Perrotti, Robert Peter Gale, Letizia Foroni, Jane F. Apperley

    Published 2019-12-01
    Get full text
    Article
  6. 6
    Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia

    Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia by Dragana Milojkovic, Emma Nicholson, Jane F. Apperley, Tessa L. Holyoake, Pat Shepherd, Mark W. Drummond, Richard Szydlo, Marco Bua, Letizia Foroni, Alistair Reid, Jamshid S. Khorashad, Hugues de Lavallade, Katy Rezvani, Christos Paliompeis, John M. Goldman, David Marin

    Published 2010-02-01
    Get full text
    Article
  7. 7
    The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial

    The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial by David I. Marks, Anthony V. Moorman, Lucy Chilton, Elisabeth Paietta, Amir Enshaie, Gordon DeWald, Christine J. Harrison, Adele K. Fielding, Letizia Foroni, Anthony H. Goldstone, Mark R. Litzow, Selina M. Luger, Andrew K. McMillan, Janis Racevskis, Jacob M. Rowe, Martin S. Tallman, Peter Wiernik, Hillard M. Lazarus

    Published 2013-06-01
    Get full text
    Article

Search Tools: